Incyte Corp (NASDAQ:INCY) - Share price - Overview

Stock Report

Incyte Corp INCY

Last Price
$121.19

Day Change
-0.55|-0.45%

As of 18/08/2017
16:08:21 EDT | USD
Minimum 15 Minutes Delay.

Last Close121.74
Day Range121.00 - 122.47
Mkt Cap-
52-Wk Range75.52 - 153.15
Yield %-
ISINUS45337C1027
Volume951,437
P/E-159.46
P/S18.42
P/CF180.50

Share Price

Financials
201420152016
More ...
Income Statement
Revenue511.50753.751,105.72
Operating Income-4.8050.65145.00
Net Income-48.486.53104.22
Basic EPS-0.290.040.55
Avg. Diluted Shares Outstanding168187194
Balance Sheet
Current Assets699.21842.38994.18
Non Current Assets130.86165.07644.42
Total Assets830.071,007.441,638.60
Current Liabilities221.52168.01273.50
Total Liabilities911.70836.291,219.13
Total Equity-81.63171.16419.47
Cash Flow
Operating Cash Flow26.2686.54304.76
Capital Expenditure-27.88-26.00-120.28
Free Cash Flow-1.6260.53184.48

In millions, except "Basic EPS". Currency is USD.

Company Profile

Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

980
Key Stats
More ...
Price/Earning TTM-160.18
Price/Book24.39
Price/Sales TTM19.34
Rev Growth (3 year avg)46.05
EPS Growth (3 year avg)-
Operating Margin % TTM13.11
Net Margin % TTM9.43
ROE TTM35.29
Debt/Equity1.55
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.